Skip to main content
NPJ Science of Food logoLink to NPJ Science of Food
. 2026 Mar 5;10:131. doi: 10.1038/s41538-026-00785-9

Gut microbiome modulation by cricket, pea, and whey protein using the SHIME in vitro simulator

Irene Franciosa 1, Gabriele Castelnuovo 2, Carolina Cantele 1, Vladimiro Cardenia 1, Simona Bo 2, Valentina Ponzo 2, Ilaria Goitre 2, Erica Pontonio 3, Dora Tortarolo 4, Michela Verni 5, Elisabetta Bugianesi 2, Francesca Cordero 4, Marco Beccuti 4, Luca Cocolin 1, Ilario Ferrocino 1,✉
PMCID: PMC13086921  PMID: 41786764

Abstract

Entomophagy is increasingly popular, and Acheta domesticus offers an ecologically sustainable protein alternative, but the effects on the human gut microbiome need further investigation. In this study, we investigated the impact of the intake of three isolated proteins: pea (plant), whey (animal), and cricket (insect) on gut microbiome of a single-donor using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). Cricket protein intake was associated with potential beneficial taxa such as Bifidobacterium and Lactobacillus, genes related to vitamin biosynthesis and bacteriocin transport, and short and medium-chain fatty acids. Pea protein intake was associated with Faecalibacterium and Slackia, while whey protein with Butyricimonas and Lactobacillus. Metagenomic analysis revealed that pea intake led to increased lysine degradation genes, promoting SCFAs production. Each protein has its own unique characteristics that may contribute positively to gut health. Specifically, cricket protein intake appears to have beneficial effects, promoting the growth of potentially beneficial taxa and enhancing short-chain fatty acid production. The results of this study indicate that cricket protein does not exhibit any detrimental effects compared to pea and whey proteins.

Subject terms: Biotechnology, Microbiology, Zoology

Background

Shift in dietary protein is required to meet the demographic growth as well as the new dietary guidelines that encourage populations to increase their protein intake1. Sustainability is also an important factor that must be taken into the account when a novel protein is chosen2.

It is well known that microbiome acts as an intermediary between diet, host physiology and health3,4 and the different aminoacidic composition of proteins can have a huge impact on the gastrointestinal microbiome5. Among various nutrients, proteins in general have garnered significant attention due to their function as primary substrates for short-chain fatty acids (SCFAs), branched-chain amino acids (BCAAs) and nitrogen that can impact host health by reducing disease risks5,6. Butyrate, acetate, and propionate are SCFAs crucial for human health as they modulate the immune system, regulate metabolic pathways, and restore the gut barrier. Numerous studies have shown that dietary interventions can enhance the population of SCFA-producing bacteria7–9. In vivo, the breakdown of proteins begins in upper part of the gastro-intestinal tract and peptides that are not digested or absorbed in the small intestine were metabolized by the colonic microbiome with the production of SCFAs, BCAAs, ammonia, amines, sulphur compounds, phenols, and indoles among others5,10. Animal and plant-based proteins have a substantial environmental impact due to high water consumption and greenhouse gas emissions during farming and post-processing11,12. Insect-based proteins are a sustainable alternative4,11,12, offering several health benefits11. Entomophagy is a practice widely used in Asia, Africa, and Latin America were more than 2000 insect species are daily consumed. Edible insects are considered an excellent source of nutrients, such as fibers, vitamins and minerals, mono- and polyunsaturated fats, essential amino acids and biologically active peptides with anti-hyperglycaemia, anti-hypertension, anti-tumour, anti-inflammation, and anti-obesity effects11,13,14.

At the same time, it is crucial to consider the potential risks associated with the consumption of edible insects, particularly due to the presence of anti-nutritive factors in their composition and the effect on the gut microbiome. Additionally, safety concerns may arise from the possible presence of allergens, heavy metals, pesticides, mycotoxins, and microbial contaminants11. Insect farming needs good manufacturing practice in order to ensure safety and quality15. In the European Union, few edible insects are classified as novel foods and are regulated under Regulation (EU) 2015/2283 and its implementation. To date, four insect species have been authorized as novel foods, including Tenebrio molitor, Locusta migratoria, Alphitobius diaperinus larvae, and Acheta domesticus (EU 2023/5). Among them, Acheta domesticus (the common house cricket) is one of the most studied, for its high content in essential amino acids16.

Recently, was observed that cricket protein intake in healthy volunteers was associated with reduced systemic inflammation and TNF-α, and improved gut health with increased abundance of Bifidobacterium17.

The lack of in vivo data on the effects of insects or their derivatives on humans in Western countries may be partly due to food neophobia, which represents a significant barrier to the design and implementation of dietary intervention trials. Protein-based fortified products, such as protein beverage are continuously growing in popularity, especially for athletes, since can be a convenient option to supply a high dose of protein18. These drinks involve just the dissolution of crude isolate protein powders, typically in water, before consumption. From a future perspective, evaluating insect-derived proteins within familiar food matrices is essential not only to better reflect real-life dietary exposure, but also to improve consumer acceptance and mitigate food neophobia, which currently represents a major barrier to the adoption of insect-based foods19.

The search for alternative protein sources is becoming increasingly crucial in the face of global food security challenges and environmental sustainability concerns. Among these alternatives, insect-derived proteins stand out due to their high nutritional value, low ecological footprint, and potential to promote gut health. The aim of this study was to investigate the effects on gut microbiome of a single donor of three isolate proteins: whey, pea, and Acheta domesticus pure water-soluble to simulate a daily ingestion using the Simulator of the Human Intestinal Microbial Ecosystem or SHIME®20–22. The impact of these proteins on microbiome was assessed through multiomics approach (metataxonomic, metagenomics, and metabolomics analyses).

Results

Aminoacid composition of isolate proteins

The total free aminoacid (TFAA) concentration before the in vitro digestion reached 17561 mg/kg for cricket, 784 mg/kg for pea and 355 mg/kg for whey and increased after digestion to 26037, 36425 and 2478 mg/kg for cricket, pea and whey protein isolate, respectively (Table 1). Although characterized by the initial highest concentration, TFAA of cricket powder was subjected to the lowest increase after digestion (about 40%).

Table 1.

Concentration of free amino acids (mg/kg) in whey, pea, and cricket protein powders before (crude proteins) and after in vitro gastrointestinal digestion

Crude proteins Digested proteins
Amino acid Cricket Pea Whey Cricket Pea Whey
Alanine 1941.2 ± 105.6ᵇ 9.7 ± 1.0ᵃ 1.3 ± 0.1ᵃ 1748.7 ± 30.8ᶜ 374.4 ± 26.5ᵇ 181.5 ± 8.4ᵃ
Ammonia 34.0 ± 2.6ᶜ 7.6 ± 0.3ᵇ 2.2 ± 0.0ᵃ 158.5 ± 8.2ᵇ 339.8 ± 25.4ᶜ 1.0 ± 0.1ᵃ
Arginine 21.7 ± 0.8ᶜ 2.5 ± 0.2ᵇ 0.0 ± 0.0ᵃ 386.4 ± 11.5ᵇ 1215.2 ± 22.3ᶜ 101.8 ± 6.1ᵃ
Asparagine 240.0 ± 9.9ᵇ 1.1 ± 0.0ᵃ 5.4 ± 0.4ᵃ 306.6 ± 21.6ᶜ 118.4 ± 8.8ᵇ 25.5 ± 2.5ᵃ
Aspartic acid 283.5 ± 16.4ᵇ 7.3 ± 0.1ᵃ 1.6 ± 0.2ᵃ 327.2 ± 9.8ᶜ 73.0 ± 7.4ᵇ 1.4 ± 0.1ᵃ
Cysteine* 1398.2 ± 39.7ᵇ 34.4 ± 4.2ᵃ 0.0 ± 0.0ᵃ 106.8 ± 5.3ᵇ 296.5 ± 33.5ᶜ 53.4 ± 6.9ᵃ
γ-Aminobutyric acid 99.1 ± 7.0ᶜ 18.4 ± 1.6ᵇ 2.4 ± 0.1ᵃ 1407.6 ± 40.4ᵇ 2534.3 ± 19.3ᶜ 204.8 ± 24.4ᵃ
Glutamic acid 1511.6 ± 49.1ᵇ 8.7 ± 0.9ᵃ 1.7 ± 0.2ᵃ 1226.7 ± 59.9ᵇ 96.4 ± 11.6ᵃ 11.1 ± 1.2ᵃ
Glycine 1531.2 ± 150.5ᵇ 8.8 ± 0.6ᵃ 1.1 ± 0.1ᵃ 2038.0 ± 28.8ᶜ 317.8 ± 21.5ᵇ 150.6 ± 15.3ᵃ
Histidine* 624.8 ± 54.7ᵇ 13.6 ± 0.9ᵃ 1.2 ± 0.1ᵃ 2936.7 ± 102.7ᵇ 5394.3 ± 52.4ᶜ 482.4 ± 14.7ᵃ
Isoleucine 91.5 ± 6.1ᵇ 2.6 ± 0.1ᵃ 0.0 ± 0.0ᵃ 882.7 ± 77.0ᵇ 904.5 ± 43.5ᵇ 50.3 ± 3.5ᵃ
Leucine* 266.7 ± 10.7ᵇ 7.8 ± 0.3ᵃ 0.0 ± 0.0ᵃ 960.7 ± 96.1ᵇ 3440.1 ± 207.7ᶜ 18.3 ± 1.8ᵃ
Lysine* 59.3 ± 3.0ᶜ 13.4 ± 0.2ᵇ 0.0 ± 0.0ᵃ 129.1 ± 4.6ᵇ 438.4 ± 27.8ᶜ 13.7 ± 1.5ᵃ
Methionine* 13.5 ± 0.6ᵇ 2.5 ± 0.2ᵃ 13.9 ± 3.7ᵇ 929.4 ± 20.7ᶜ 511.5 ± 27.6ᵇ 0.9 ± 0.1ᵃ
Ornithine 1878.2 ± 153.9ᵇ 501.7 ± 14.0ᵃ 286.6 ± 20.4ᵃ 2276.8 ± 66.2ᵇ 2792.6 ± 22.9ᶜ 215.4 ± 14.0ᵃ
Phenylalanine* 581.8 ± 71.9ᵇ 16.3 ± 1.7ᵃ 0.0 ± 0.0ᵃ 2630.0 ± 65.6ᵇ 2858.9 ± 30.2ᶜ 215.1 ± 9.6ᵃ
Proline 1939.5 ± 123.7ᵇ 4.6 ± 0.2ᵃ 2.1 ± 0.1ᵃ 5155.4 ± 537.5ᵇ 8748.8 ± 640.6ᶜ 233.3 ± 15.8ᵃ
Serine 492.8 ± 9.1ᵇ 2.6 ± 0.2ᵃ 0.0 ± 0.0ᵃ 469.4 ± 43.2ᵇ 396.0 ± 33.5ᵇ 15.7 ± 1.3ᵃ
Threonine* 488.2 ± 34.6ᵇ 5.2 ± 0.3ᵃ 2.3 ± 0.3ᵃ 575.4 ± 40.9ᶜ 475.9 ± 8.0ᵇ 17.4 ± 0.7ᵃ
Tryptophan* 474.2 ± 48.8ᵇ 5.5 ± 0.5ᵃ 1.2 ± 0.0ᵃ 573.0 ± 12.9ᵇ 742.1 ± 7.4ᶜ 31.6 ± 1.0ᵃ
Tyrosine* 679.0 ± 45.2ᵇ 61.7 ± 2.9ᵃ 30.8 ± 2.1ᵃ 3.5 ± 0.3ᵃ 4355.1 ± 11.2ᶜ 366.3 ± 27.4ᵇ
Valine* 2911.0 ± 59.4ᵇ 48.0 ± 2.9ᵃ 1.9 ± 0.1ᵃ 808.9 ± 38.7ᶜ 1.7 ± 0.1ᵃ 86.9 ± 5.4ᵇ

Values are expressed as mean ± standard deviation. For each amino acid and digestion condition, differences among protein sources were assessed by one-way ANOVA followed by Tukey’s post hoc test. Different superscript lowercase letters (a-c) within the same row, separately for crude and digested proteins, indicate statistically significant differences among protein sources (p < 0.05). Amino acids marked with an asterisk (*) are essential amino acids.

Cricket proteins showed the highest concentrations of several amino acids, in some cases up to 1000 times higher than in pea and whey. The most abundant were valine, proline, alanine, ornithine, glutamic acid, glycine, and cysteine. Lower concentrations were observed for arginine, lysine, and methionine. Pea protein included high levels of ornithine, tyrosine, valine, cysteine, γ-aminobutyric acid, phenylalanine, histidine, and lysine.

Whey powder primarily contained ornithine, followed by tyrosine and methionine, with generally lower amino acid concentrations compared to the other sources.

After digestion, the concentration of all amino acids increased regardless of the protein used (Table 1). Although cricket protein showed the highest total amino acid content, it exhibited the lowest relative increase after digestion, approximately 40%. Nine out of 21 amino acids exceeded 1000 mg/kg.

Among these, the highest concentration was observed for proline (5107 mg/kg), followed by tyrosine (3569 mg/kg), histidine (2915 mg/kg), glycine (2001 mg/kg), phenylalanine (2626 mg/kg), ornithine (2270 mg/kg), γ-aminobutyric acid (1342 mg/kg), alanine (1746 mg/kg), and glutamic acid (1214 mg/kg). Pea protein was also rich in amino acids after digestion, with eight out of 21 showing concentrations above 1000 mg/kg. The amino acid with the highest concentration was proline (8303 mg/kg), followed by histidine (5408 mg/kg), tyrosine (4375 mg/kg), leucine (3364 mg/kg), phenylalanine (2857 mg/kg), ornithine (2784 mg/kg), γ-aminobutyric acid (2539 mg/kg), valine (1802 mg/kg), and arginine (1163 mg/kg). Whey protein showed the lowest overall amino acid content and included the histidine (4844 mg/kg), followed by tyrosine (369 mg/kg), phenylalanine (220 mg/kg), ornithine (215 mg/kg), proline (242 mg/kg), alanine (180 mg/kg), γ-aminobutyric acid (199 mg/kg), glycine (152 mg/kg), and arginine (104 mg/kg) (Table 1).

By comparing the concentration of amino acids between the three types of protein after digestion, cricket displays significantly higher concentrations of alanine, glutamic acid, glycine, methionine, serine, threonine, and valine, while pea shows higher concentrations of arginine, cysteine, γ-aminobutyric acid, histidine, leucine, lysine, ornithine, phenylalanine, proline, tryptophan, and tyrosine (Table 1, ANOVA, P < 0.05).

Donor characteristic

From questionnaire analysis, the subject demonstrated high adherence to the MDS with a score of 10 out of 14, as well as a high level of physical activity, achieving the criteria of “vigorous intensity activity on at least 3 days and accumulating at least 1500 MET minutes/week”23. In addition, the 3-day food record was used for assessing energy and macronutrient intakes during 2 weekdays and one weekend day prior to sample collection. In particular, the median individual macronutrient intake showed that 44% of energy intake came from carbohydrates, 19% from protein and 37% from fat. The use of a single donor allowed the evaluation of intra-individual microbiome responses to different protein intake under controlled conditions.

Microbiota dynamics during the experiment

Metataxonomic approach was used to evaluate the microbial dynamics during the experiment. Only Simpson index was significantly highest (P < 0.05) in proximal colon with pea intake, while in the distal section, the highest value was observed with cricket intake (Supplementary Fig. 1).

PERMANOVA analysis and ANOSIM tests showed that microbiota variation was primarily influenced by colonic section (distal or proximal, R² = 19.6%, P < 0.01), followed by sample type (lumen or mucin-associated microbiota (R² = 15.6%, P < 0.01) and then sampling time (R² = 15.6%, P < 0.01). Protein intake accounts for 13.5% of the variance, confirming a dietary impact, though less pronounced than section or sample type. Period (control, treatment, washout) was also significant but explains a smaller portion of the variance (9.3%, P < 0.01). Non-metric multi-dimensional scaling (NMDS) analyses based on ASVs at genus level showed that cricket intake was able to modify the structure of the microbiota since pea and whey clustered together and were well separated from cricket in both period (treatment or washout) or sample type (lumen or mucin) (P < 0.05, Fig. 1).

Fig. 1. Non-metric Multi-Dimensional Scaling (NMDS) of microbiota assessed by amplicon sequencing, based on Bray-Curtis distance.

Fig. 1

Samples are colour-coded according to the protein intake (cricket, pea and whey), while the shape according to the SHIME® section (proximal, distal or mucin), numbers represent the sampling day. Each panel showed an experimental period (control, treatment and washout).

At genus level, we observed that Enterocloster and Bacteroides were the most abundant ASVs, followed by Phocaeicola, Parabacteroides and Sutterella (Fig. 2A). In general, we observed an increase in frequency of the minor ASVs during the treatments followed by a gradual decrease during wash out (Fig. 2A). This trend was observed for Lachnospira and Fusobacterium in mucin-whey, Lactobacillus in proximal colon-whey samples, Alistipes and Enterococcus in distal colon-pea samples. Cricket intake increased the presence of Proteus in mucosa samples during the second week of treatment, while Veillonella in the washout (Fig. 2A). Bifidobacterium was mainly present in lumen samples (distal and proximal) with cricket intake (Fig. 2A). Collinsella increased its relative frequency in the mucin layer samples especially with whey intake, while Megasphaeraceae showed an increase with pea intake in distal section (Fig. 2A).

Fig. 2. Global composition of microbiota at genus level assessed by 16S rRNA gene sequencing during the experiment.

Fig. 2

A Bar plot illustrating the microbiota composition according to protein intake (cricket, pea, and whey) and SHIME® section (proximal, distal, or mucin), with sampling points indicated along the x-axis. Only Amplicon Sequence Variants (ASVs) with a relative frequency > 0.5% in at least 10% of the samples are shown. B Bubble plot showing the ASVs significantly associated with specific protein intakes across the three SHIME® sections, as determined by the indicator species analysis. Bubbles are color-coded according to protein intake (cricket, pea, and whey), and the size of each bubble corresponds to the p-value of the association. Larger bubbles indicate a lower p-value, reflecting a stronger association between an ASVs and a specific protein intake.

The indicator species analyses performed for each colonic region showed in distal tract that cricket intake was associated with the predominance of Blautia, Dorea, Lawsonibacter, and Comamonas among others (Fig. 2B, FDR < 0.05). Pea intake with Alistipes, Enterococcus, Megasphaeraceae and Slackia, while whey intake with Collinsella, Escherichia and Lactobacillus (Fig. 2B, FDR < 0.05). In solid layer simulated by the mucin, we observed that Bifidobacterium, Intestinibacter, Lachnospiraceae, Lentilactobacillus and Parabacteroides were associated with cricket intake, Acinetobacter, Enterococcus, Roseburia and Slackia with pea, Butyricimonas and Fusobacterium with whey intake (Fig. 2B, FDR < 0.05). In the proximal section, cricket intake was associated with Clostridium, Lachnospira, Corynebacterium, Dorea, and Enterobacteriaceae.

To identify differentially features across protein intake, we performed a pairwise comparisons between each treatment. A linear model was constructed to account for variables such as feed type, period, section, and time.

From the model, we observed that Bifidobacterium, Blautia, Clostridium, Dorea, Intestinibacter, Lachnospira, Lactiplantibacillus, Lactobacillus, and Lentilactobacillus were significantly more abundant with cricket intake when compared with pea or whey (Fig. 3A, FDR < 0.01).

Fig. 3. Differential microbial abundance across protein sources based on amplicon sequencing and shotgun metagenomics analyses.

Fig. 3

Plot A: bar plots shows the differential abundance of Amplicon Sequence Variants (ASVs) for three protein intake comparisons: Pea vs. Cricket, Whey vs. Cricket, and Whey vs. Pea. The fill color of each bar represents the protein: red for cricket, green for pea, and blue for whey. The x-axis represents different ASVs, reordered by log fold change (log2), which was calculated using a linear modeling approach applied with the lmFit function from the limma package in R. P-values were adjusted for multiple comparisons using the Benjamini–Hochberg procedure to control the False Discovery Rate (FDR). The y-axis shows the log fold change values, where bars above the x-axis indicate higher abundance in the first protein listed in the comparison, and bars below the x-axis indicate higher abundance in the second protein. Plot B shows the differential abundance of species detected by shotgun metagenomics for the same three protein intake comparisons.

In contrast, Alistipes, Enterococcus, Faecalibacterium, Fusobacterium, Slackia, and Sutterella were linked to pea intake, while Butyricimonas, Collinsella, Escherichia, Fusobacterium, Lactobacillus, and Sutterella were associated with whey when compared to cricket intake (Fig. 3A, FDR < 0.01).

By comparing whey and pea intake, we observed an association between Alistipes, Enterococcus, Bacteroides, Faecalibacterium, Blautia and Slackia with pea intake and Acinetobacter, Clostridium, Lentilactobacillus and Lactobacillus with whey (Fig. 3A, FDR < 0.01).

For all the comparison Intestinimonas, Lactiplantibacillus, Pseudomonas, Intestinibacter and Lentilactobacillus were always associated with cricket intake (Fig. 3A, FDR < 0.01).

Protein intake modulates the microbiome at strain level

The microbiome composition variation conducted using Kraken was consistent with the results from metataxonomic 16S rRNA gene sequencing. The statistical linear models confirmed the association of Blautia coccoides, Lentilactobacillus parabuchneri, and Bifidobacterium angulatum with cricket intake (Fig. 3B, FDR < 0.01). Pea intake was linked to several Bacteroides (including B. uniformis and B. thetaiotaomicron) and Faecalibacterium species, while whey intake was associated with Phocaeicola dorei, Bacteroides uniformis and Bifidobacterium catenulatum (Fig. 3B, FDR < 0.01). A total of 64 metagenome-assembled genomes (MAGs) were reconstructed, all with completeness greater than 90% and contamination below 5%. The distribution of these MAGs varied depending on the type of food intake (Supplementary Fig. 2). Cricket intake was associated with several species-level genome bins (SGBs) such as Clostridium bolteae, Parabacteroides distasonis, Intestinimonas butyriciproducens, and Bifidobacterium angulatum, with Lactiplantibacillus plantarum and Lactobacillus buchneri being reconstructed exclusively whit cricket. In the pea-fed group, Desulfovibrio vulgaris, Faecalibacterium prausnitzii, Selenomonas sp., and Enterococcus faecium were the most prevalent. Whey protein intake was primarily characterized by Bacteroides dorei, Bacteroides fragilis, and Lactobacillus johnsonii. Core taxa such as Lachnoclostridium sp. and Alistipes finegoldii were consistently abundant across all dietary treatments (Supplementary Fig. 2).

Protein intake modulates the potential function of the microbiome

Shotgun data were used to discover the functional potential of microbiome due to the different protein intake.

Once comparing cricket vs. pea protein intake, the functional gene clusters at level 2 showed that cricket intake boosted an increase of genes involved in protein secretion systems, as well as those involved in metabolism of aromatic compounds, proteolysis and amino acid metabolism, such as peptidases and aminotransferases (Fig. 4A, FDR < 0.01). Pea intake busted the genes involved in protein degradation and biosynthesis, alongside those related to histidine metabolism, DNA replication, and membrane transport.

Fig. 4. Differential abundance analysis of functional genes (Subsystem Level 2) and metabolites across protein intake comparisons.

Fig. 4

Plot A: bar plots show the differential abundance of genes at Subsystem Level 2 for three protein intake comparisons: Pea vs. Cricket, Whey vs. Cricket, and Whey vs. Pea. The fill color of each bar represents the protein: red for cricket, green for pea, and blue for whey. The x-axis represents different genes at Subsystem Level 2, reordered by log fold change (log2), which was calculated using a linear modeling approach applied with the lmFit function from the limma package in R. P-values were adjusted for multiple comparisons using the Benjamini–Hochberg procedure to control the False Discovery Rate (FDR). The y-axis shows the log fold change values, where bars above the x-axis indicate higher abundance in the first protein listed in the comparison, and bars below the x-axis indicate higher abundance in the second protein. Plot B shows the differential abundance of metabolites for the same three protein intake comparisons.

Comparing whey vs. cricket, the latter displays the highest abundance of cluster genes related to organic acids and branched-chain amino acids, while whey displays the highest abundance of genes clusters for fermentation and protein processing and modification (Fig. 4A, FDR < 0.01).

Comparing pea vs. whey intake, the latter boosted gens for osmotic stress, ABC transporters, fermentation, and tricarboxylate transporters. Pea intake boosted genes involved in membrane transport, branched-chain amino acid metabolism, and protein folding (Fig. 4A, FDR < 0.01)

At function level, when we compared cricket-protein with pea protein intake, we found that cricket intake was associated with a significantly higher abundance of several genes (n = 334), including branched-chain amino-acid (BCAA) transporters genes (LivF, LivH, LivM and DppC), involved in the degradation of aromatic and other amino acids, including aspartate racemase, asparagine synthase, methionine synthase, glutamate-N-acetyltransferase, and enzymes for glycine/serine metabolism (Supplementary Data 2A, FDR < 0.01). Cricket-protein intake samples also boosted several genes for bacteriocin transport (e.g., lantacin F, lactacin F) and for vitamin biosynthesis (thiamine, biotin, and riboflavin pathways). Additional signatures included universal stress proteins, starvation sensors such as RspA, and redox-active genes like putative sulfite reductase, anaerobic selenate reductase, and ferredoxin reductase (Supplementary Data 2A, FDR < 0.01). By contrast, pea protein displayed few differentially abundant genes (n = 132), including those for lysine degradation (L-β-lysine 5,6-aminomutase and D-lysine 5,6-aminomutase) and chorismate mutase II (EC 5.4.99.5/AroHII) alongside clusters linked to oxidative and nitrosative stress (heat-shock dnaK operon, periplasmic stress response). When cricket and whey protein intake were compared, whey samples were enriched in genes (n = 62) belonging to the serine–glyoxylate cycle, succinate dehydrogenase, aldehyde-lyases, and the acetoin–2,3-butanediol pathway, together with genes for bacteriocins (Supplementary Data 2B, FDR < 0.01). Cricket intake (n = 22) was characterized by glycine/sarcosine reductase, oxaloacetate decarboxylase, DMSO reductase, and enzymes involved in glutathione utilization, sulphite reduction, and sulfolactate lyase, underscoring their greater reliance on amino-acid fermentation and sulphur metabolism (Supplementary Data 2B, FDR < 0.01). Comparing whey intake versus pea, we observed that whey boosted several genes (n = 501), including transporter genes for oligo or dipeptide and bacteriocins along with genes involved in acetoin, butanediol metabolism. Pea intake significantly increased genes (n = 174) associated with proteolysis and amino acid metabolism along with peptidase and aminotransferases (Supplementary Data 2C, FDR < 0.01).

Metabolomic composition

Before treatment, the content of SCFAs did not significantly differ (P > 0.05) between the three SHIME units. The variable section explains the most variance (R2 = 20.2%, P = 0.001), followed by time (R2 = 46.8%, P = 0.001), period (R2 = 40.4%, P = 0.001) and feed (R2 = 12.1%, P = 0.013).

SCFAs composition varied according to the protein intake (Supplementary Data 3). Cricket intake led to an increase in acetic acid production, especially in distal colon. Whey intake led to a butyrogenic and propionogenic effect at the end of the first week of treatment, with the highest amount in the distal colon (Fig. 5 and Supplementary Data 3, P < 0.05). Acetic, propionic and butyric acids increased in their concentration during pea intake in both colon section at the same way. At the end of the washout period, SCFAs concentration decreased in every SHIME unit, reaching the initial concentrations (Fig. 5 and Supplementary Data 3, P < 0.05). A biplot based on the metabolomic composition was used to analyse samples from three treatments. The biplot revealed that for the SCFAs in the distal colon, the cricket samples were distinctly separated from the other groups (ANOSIM statistic R = 0.26, P = 0.001). This separation was primarily driven by the influence of the following compounds: acetic acid, hexanoic acid, heptanoic acid, valeric acid, and octanoic acid (Supplementary Fig. 3).

Fig. 5. Concentration of SCFAs (acetic, propionic, and butyric acid) over time in each SHIME® section (proximal and distal colon), according to protein intake (red for cricket, green for pea, and blue for whey).

Fig. 5

For each sampling point, the bars represent the standard deviation, and the letters indicate statistical significance based on a one-way ANOVA between protein intake. Different letters denote significant differences between protein intake, as determined by Tukey’s Honest Significant Difference (Tukey HSD) post-hoc test.

The linear models showed distinct metabolomic profiles linked to each protein intake. Cricket intake was significantly associated with a wide range of metabolites, including various short-chain fatty acids such as propionic acid, isobutyric acid, acetic acid, valeric acid, and hexanoic acid, as well as alcohols like hexan-1-ol and heptan-1-ol (Fig. 4B, FDR < 0.01). Several sulphur-containing compounds, including (methyltrisulfanyl)methane, 2,2-dimethylpropanethioic S-acid, and octathiocane, were also enriched. Pea intake showed a simpler profile, with the microbial metabolites phenol and 1H-indole being most prominent when compared with cricket or whey (Fig. 4B, FDR < 0.01). In contrast, whey intake was mainly associated with isovaleric acid, 2,2-dimethylpropanethioic S-acid, and propionic acid (Fig. 4B, FDR < 0.01).

Metabolome and microbiome correlations

The putative correlation analysis between microbiota (ASVs) and the metabolome (SCFAs and VOCs) reveals distinct relationships between gut microbial genera and various metabolites.

Alistipes shows a broad spectrum of positive associations, being directly correlated with several microbial metabolites including acetic acid, valeric acid, isobutyric acid, phenol, butan-1-ol, 1H-indole, and lauric acid (Supplementary Fig. 4, FDR < 0.01). Bacteroides exhibits consistently negative associations with a wide range of sulfur-compounds. Enterococcus displays multiple positive associations across both SCFAs (e.g., acetic, butyric, isobutyric, isovaleric acids) and sulfur-containing metabolites (e.g., (methyldisulfanyl)methane, (methyltetrasulfanyl)methane. Bifidobacterium showed positive associations with lipid-related metabolites such as undecanoic acid and dimethyl pentasulfide, while showing a negative association with phenol (Supplementary Fig. 4, FDR < 0.01). Blautia and Lachnospiraceae are positively linked to medium-chain fatty acids and alcohols, including valeric acid, heptanoic acid, heptan-1-ol, and hexan-1-ol. Lactiplantibacillus and Lactobacillus are largely negatively associated with a range of metabolites, including butyric acid, acetic acid, and phenol. Finally, Lentilactobacillus shows a positive association with octanoic acid, while being negatively associated with phenol and butan-1-ol (Supplementary Fig. 4, FDR < 0.01).

To elucidate multi-omic signatures associated with different feed protein sources, we performed a supervised multiblock sparse Partial Least Squares Discriminant Analysis (sPLS-DA) using the mixOmics R package. The analysis simultaneously integrated metabolomic, microbiome, and network-derived pathway data obtained from the same set of samples, enabling the identification of complementary features that collectively discriminate between cricket-, pea-, and whey-based diets (Supplementary Fig. 5). Predictive performance was further assessed via ROC analysis on the combined feature set. The integrated signature achieved high classification performance (AUC = 1.00) for cricket-fed samples and high discrimination for the remaining groups (AUC = 0.98 and AUC = 0.97 for pea and whey, respectively).

Discussion

Gut intestinal microbiome plays a crucial role in human health, with diet being one of the main factors influencing its composition and function. High-protein diets are often recommended for weight management, elderly populations, and athletes; however, the effects of elevated protein intake that reach the colon on microbiome composition and function are often contradictory and unexplored24. In the present study, we investigated how the colonic microbiome responds to an overexposure of dietary proteins (since the majority of dietary proteins are absorbed in the small intestine) and how animal, plant or insect-based protein influences the microbiome using a gastrointestinal simulator.

Cricket are high-protein source, providing essential amino acids, fats, minerals25 with digestibility and metabolism similar to pea and whey proteins as already assessed26. Recent studies have shown that cricket-derived compounds could modulate microbiota composition, reducing inflammation and promoting metabolic benefits27. However controlled study is required to verify the effect of novel food intake.

The three proteins exhibited a significant increase in free amino acids after in vitro digestion with whey and pea that confirmed a remarkable ability to release a large amount of free amino acids, highlighting their great digestive efficiency24. Although the amount of free amino acids released after cricket protein digestion was lower compared to the other proteins, cricket protein contained a notably high proportion of amino acids that were already free or easily accessible even before digestion. This suggests that cricket protein had higher early bioavailability of amino acids, which may be beneficial for conditions requiring fast nutrient uptake, such as post-exercise recovery or compromised digestion28,29. Specifically, crude cricket proteins showed the highest levels of free phenylalanine. As previously shown, phenylalanine is more rapidly absorbed when ingested as free amino acids, compared to its absorption from protein-derived phenylalanine30. This feature could be particularly beneficial for older adults, in whom the postprandial release of dietary protein-derived phenylalanine into circulation is often attenuated31. Furthermore, phenylalanine is an essential amino acid that plays a crucial role in the biosynthesis of dopamine, epinephrine, and norepinephrine, all of which are involved in the gut-brain axis32. When comparing the concentration of free amino acids after in vitro digestion, cricket protein displayed significantly higher concentrations of alanine, methionine, and valine. These amino acids are associated with antioxidant activity due to their ability to donate electrons and neutralize free radicals. This unique amino acid profile could contribute to the potential health-promoting properties of cricket-derived proteins, including their antioxidant capacity14.

After cricket protein digestion, significantly higher concentrations of essential amino acids such as methionine and valine and non-essential like alanine, glutamic acid, glycine, serine and threonine were observed. These AA are associated with the production of key short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate33, as well as sulphur-containing metabolites like methanethiol and hydrogen sulphide34. In contrast, pea protein was enriched in both essential amino acids (such as arginine, histidine, leucine, lysine, and tryptophan) and non-essential amino acids (such as cysteine, γ-aminobutyric acid (GABA), ornithine, proline, and tyrosine). Many of these amino acids are precursors for bioactive compounds, including polyamines, aromatic and indolic compounds, SCFAs, and neurotransmitter-like molecules (e.g., tyramine, histamine)34. We observed a direct association between cricket intake and several beneficial taxa. These include: Bifidobacterium, an anti-inflammatory and pro-homeostatic immunomodulatory taxon35; Lactiplantibacillus and Lactobacillus, known for their protective effects on intestinal epithelial cells36, neuroprotective properties37, and positive impact on colonic function38; Blautia and Lachnospira, known for their beneficial effects on gut health39–42.

Additionally, taxa with multifaceted roles, such as Clostridium43, Intestinibacter44, and Dorea45,46, were also associated with cricket intake. As is already known, the human gut microbiota exhibits taxonomic variations throughout different sections of the gastrointestinal tract6. Notably, in the simulated mucosal layer, a significant presence of Bifidobacterium, Lentilactobacillus and Parabacteroides, which are well known as potential probiotics47,48 was observed. Pea intake was associated with beneficial Faecalibacterium44,49, as well as equol-producing taxa like Slackia50,51. However, potentially detrimental taxa such as Enterococcus52,53, Sutterella, which has been positively correlated with HOMA-IR54,55, Fusobacterium56,57 and Alistipes were also associated with pea consumption. In particular, Alistipes has a controversial role due to its ability to produce harmful metabolites, including phenol and indole, as previously reported58.

Whey intake was associated with Butyricimonas, a SCFAs-producing bacterium59, as well as Lactobacillus. Moreover, whey was linked to the controversial genus Collinsella, which has been associated with insulin resistance and obesity60,61, as well as with Fusobacterium and Sutterella.

At species level, cricket intake enriched the prevalence of Bifidobacterium angulatum, which is capable of producing gamma-aminobutyric acid (GABA), playing a role in the functioning of the gut-brain axis62. It has already been observed that cricket intake increases the abundance of Bifidobacterium17.

Additionally, it increased the presence of histamine-producing Lentilactobacillus parabuchneri63. Under normal conditions, histamine helps modulate immune responses, gut motility, and other physiological functions64,65. For pea intake, we observed that several Bacteroides species, including B. uniformis and B. thetaiotaomicron, were associated with this protein. These species play a potential role in alleviating obesity66, while Bifidobacterium catenulatum has been shown to confer liver protection67. Regarding the predominance of Bacteroides, it was already reported that protein would increase substrate availability for these bacteria, due to their proteolytic activity and supporting their growth over other bacteria belonging to Firmicutes68.

The shift in microbiota composition also reflects a shift in the metagenomic function. In our experiment, cricket intake led to an increase in genes involved in the biosynthesis of B-vitamins, highlighting a potential stimulatory effect of insect-based proteins on microbiome for vitamin production. Previous studies have shown that microbiome-based vitamin production can vary depending on the host’s health status and dietary habits69. Furthermore, the gut microbiota possesses a remarkable ability to synthesize and utilize B-vitamins when dietary carbohydrates are insufficient and protein levels are high, favouring proteolytic bacteria that metabolize amino acids to support B-vitamin production70. This suggests that the high protein content in cricket-based diets may create an environment that enhances B-vitamin biosynthesis by modulating the microbiota. Additionally, vitamins, especially B-vitamins, play a significant gastroprotective role due to their antioxidant, anti-aging, and anti-inflammatory effects71. Cricket intake increase the BCAA transport genes suggesting an adaptive response of the microbiome to efficiently manage the availability of these amino acids. Highest level of circulating BCAA was reported to be associated with increased of insulin resistance72,73, however, the highest abundance of BCAA transport genes suggests that, through this pathway, the gut microbiome could contribute to lower BCAA levels in circulation74. We then observed that insect proteins increased the abundance of genes involved in bacteriocin transport that can offer a competitive advantage to lactic acid bacteria by reducing microbial competition and inhibiting the growth of harmful microbes75, thereby potentially contributing to the enrichment of beneficial microbes in the gut. By comparing cricket and pea protein intake, the latter ones display the highest abundance of lysins, and as a consequence, several genes involved in its degradation, with the consequent production of SCFAs76 were observed. In line with literature, protein intake enriched in the entire dataset several microbial proteases as well as transporters, indicated a highest aminoacid fermentations. As a consequence, we then observed a variety of metabolites of protein fermentation including, including SCFAs, phenols, ammonia, amines and indoles.

Due to the aminoacidic composition, cricket protein may thus promote higher acetate production33. Acetate can inhibit the growth of pathogens77,78 and acts as a co-substrate to support the growth of other beneficial microbes, such as Lactobacillus79, through cross-feeding mechanisms. Furthermore, acetate contributes to lipid biosynthesis79 and has been associated with appetite regulation80. We then observed higher levels of propionic acid due to protein intake when comparing to pea intake. It has been demonstrated that propionic acid lowers fatty acid content in liver and plasma, reduces food intake, exerts immunosuppressive actions81, and may improve tissue insulin sensitivity82, while also helping to control intestinal inflammation80,83. Cricket protein supplementation boosted the production of medium-chain fatty acids (MCFAs), including hexanoic, heptanoic, octanoic, and lauric acid. These MCFAs are more rapidly absorbed from the gut and transported directly to the liver via the portal vein and play a role in regulating glucose and lipid metabolism84,85. The SCFA-enhancing effects of cricket-derived amino acids are functionally reflected in the correlations observed for Blautia and Lachnospiraceae with MCFAs and SCFAs, supporting a microbiota-mediated mechanism through which dietary proteins modulate host metabolism. Lauric acid, in particular, exhibits a broad spectrum of antimicrobial activities against and helping to maintain the balance of gut microbiota86. However, the metabolism of cricket protein also results in the production of trimethylamine, which has been associated with negative health outcomes for the host24. Pea protein intake was primarily characterized by the highest levels of tyrosine and tryptophan, which subsequently led to elevated concentrations of phenol and indole, as already reported87. The potentially detrimental effects of indole, phenol, and their derivatives are acknowledged, including their association with oxidative stress and the reduction of gut epithelial barrier function24,88–90. The putative correlation analysis between microbiota and metabolite profiles (SCFAs and VOCs) supports and expands upon the functional differences observed among protein intake. The correlation analyses between the microbiome and metabolome across the treatments revealed the association between the pea associated Alistipes with indole and phenol, as well as acetic acid, reinforced its controversial role in human gut58. Enterococcus, enriched by pea protein intake, was positively correlated with SCFAs and sulphur compounds. Its ability to decarboxylate tyrosine, abundant in pea protein, may contribute to the production of bioactive metabolites like tyramine, with potential neuromodulatory effects34. Cricket protein promoted elevated levels of SCFAs (e.g., acetate and propionate) and medium-chain fatty acids (e.g., octanoic and lauric acid), which were associations with Lentilactobacillus (with octanoic acid). The enrichment of Lactiplantibacillus and Lactobacillus after cricket consumption, together with their negative correlations with acetic acid and phenol, suggests a role in modulating excessive fermentation or potential harmful aromatic compounds. Bifidobacterium, stimulated by cricket intake as already observed17 was correlated with lipid-derived compounds such as undecanoic acid, and its negative correlation with phenol, reinforces its protective function, possibly aided by its ability to metabolize accessible amino acids into less harmful products.

In conclusion, the results of this study indicate that cricket protein does not exhibit any detrimental effects compared to pea and whey proteins. Each protein intake has its own unique characteristics that may contribute positively to gut health. In the context of a single-donor model and in the absence of the whole food matrix, exposure to cricket protein was associated with changes in the gut microbiome, including an increased abundance of potentially beneficial microbial taxa and enhanced short-chain fatty acid production. Moreover, pea and whey proteins also show positive microbiome modulation, cricket protein’s impact is notably favourable. The use of a single donor allowed the evaluation of intra-individual microbiome dynamics under controlled experimental conditions; however, inter-individual variability was not addressed and represents an important limitation of the study. However, it is important to note that in our simulated SHIME® system, the food matrix was not present, meaning potential synergistic effects from compounds in the whole food form, such as for pea protein, may not be fully represented. Nonprotein dietary components can influence the availability of protein and offer additional substrates to the microbiota, as already discussed24. Despite SHIME® providing critical insights, it does not replicate systemic and host-level responses in living organisms, making in vivo validation necessary for a comprehensive understanding of gut microbiota-related interventions22.

Since the gut microbiome can regulate the host’s status, significant inter-personal variation within the human population may mask the dietary effects observed in vitro91. Therefore, while these findings suggest that cricket protein is a promising alternative protein source, they should be considered donor-specific, highlighting the need for further studies involving multiple donors and in vivo validation to fully assess long-term effects on gut health.

Future research should evaluate insect-derived proteins within real and familiar food matrices in order to assess their overall nutritional and microbiome-related effects. This approach may also improve consumer acceptance in Western countries and help overcome food neophobia while better reflecting real-life dietary exposure.

Methods

Chemicals and reagents

Chemicals used in this study were of analytical grade. Diethyl ether and sodium hydroxide were purchased from Carlo Erba (Milan, Italy), while 1-octanol, 4-pentenoic acid, sulfuric acid (95-97%), and sodium chloride were acquired from Merck (Darmstadt, Germany). All the fatty acids used in the study were obtained from Sigma Aldrich (St. Louis MO, USA). Double distilled water was obtained with a Milli-Q filter system (Millipore, Milan, Italy). Ringer’ solution was purchased from VWR (Milan, Italy). The reagents (Feed media, hydrochloric acid 0.5 M, sodium hydroxide 0.5 M, mucin powder, pancreatin powder) were acquired from ProDigest® (Gent, Belgium), while sodium hydrogen carbonate was supplied from Fisher Chemical (Milan, Italy) and Oxgall dehydrated fresh bile from BD (Milan, Italy). All the reagents and enzymes for the INFOGEST protocol were obtained from Sigma (Milan, Italy). Reagents for amino acid analysis were obtained from ERRECI S.r.l. (Milan). Hydrochloric acid (HCl), Trizma® base (NH2C(CH2OH)3), 5-Sulfosalicylic acid dihydrate (C7H6O6S) used for the water/salt soluble extract were purchased from Merck (St. Louis, Missouri, USA). Reagents for the DNA extraction were supplied by QIAGEN (Milan, Italy), while the reagents for the PCR and library preparation from Roche (Milan, Italy).

Raw ingredients and in vitro digestion

Three commercial isolate proteins: pea protein isolate unflavoured (Pea protein isolate, Bulk®); whey protein isolate unflavoured (Whey protein, Decathlon), and defatted Acheta domesticus isolate protein (Nutri, Italian Cricket farm srl.) were selected and used in the experiment. To mimic the use levels of the European Regulation in foods for insects, an intake of 10 g of each pure protein per day was considered. Proteins were pre-digest following the INFOGEST static in vitro simulation of gastrointestinal digestion protocol92.

Amino acidic profile of pure protein proteins

Water/salt-soluble extracts from protein isolate prior to and after the INFOGEST were prepared according to the method described by Weiss et al.93. Briefly, a 1:4 ratio of sample to Tris–HCl buffer (50 mM, pH 8.8) was used. Samples were resuspended in the buffer and held at 4 °C for 1 hour under stirring conditions (150 rpm), followed by centrifugation at 20,000 × g for 20 min. The obtained supernatants were used for the determination of total free amino acids (TFAA) by using a Biochrom 30+ series Automatic Amino Acid Analyzer (Biochrom Ltd., Cambridge Science Park, United Kingdom), equipped with a Li-cation-exchange column (4.6 × 200 mm internal diameter)94. Results are reported as mean ± standard deviation of three independent analyses and expressed as mg/kg of protein isolate.

Participant and ethical aspects

A 34-year-old healthy individual with a normal weight (Body Mass Index = 22 kg/m2) who was following an omnivorous diet was selected after conducting a detailed interview to assess suitability for the study. The subject, voluntarily recruited in February 2024, had no medical conditions, was not taking chronic medications or prebiotics and had no history of gastrointestinal diseases, eating disorders, chronic or psychiatric illnesses, recent antibiotics, or surgery. To ensure the participant meets the health and activity criteria required for the study, the individual completed the 14-item Mediterranean Diet Score (MDS)95, which was used to assess the adherence to the Mediterranean-type regimen. Physical activity levels were calculated using the International Physical Activity Questionnaire (IPAQ) Short Form23,96. Additionally, dietary habits over the 3-day food record97, was completed in the days prior to sample collection. Stool samples were self-collected by volunteers98 immediately kept at 4 °C in anaerobic conditions, and reached the laboratory approximal within 1 hour. The volunteer gave written informed consent to the study, and the study protocol was approved by the Ethics Committee of the University of Turin (approval n° 0416051 12/07/2024) in accordance with the Declaration of Helsinki.

Simulator of the human intestinal microbial ecosystem

A Triple M-SHIME® (ProDigest, Ghent, Belgium) configuration was design. Each parallel SHIME® unit includes three consecutive bioreactors that simulate: stomach and small intestine (ST/SI), proximal colon (PC) and distal colon (DC). Bioreactors temperature was maintained at 37 °C under anaerobic conditions by flushing sterile N299,100. PC and DC bioreactors were filled with 500 and 800 mL of adult M-SHIME growth medium with starch (PD-NM002B Prodigest, Belgium), and the pH was maintained constant through computer-controlled addition of 0.5 M HCl and 0.5 M NaOH within the following ranges: 5.75–5.95 and 6.6–6.9, respectively22. Each DC bioreactor has an artificial mucosal layer, consisting in two polyethylene netting containing 30 mucin agar-covered plastic media101. All PC and DC bioreactors were inoculated with the selected donor fresh stool slurry (5% v/v)20. The inoculated microbiota had around 16 h100 of adaptation by a static incubation in the bioreactors following by 2 weeks of stabilization, allowed the evolution of the stable colonic microbiota within colon bioreactors, and then 2 weeks of steady state, which representing the experiment baseline. During these weeks, the bioreactors were fed three times per day with the appropriate M-SHIME media with pH adjusted to 2 (PD-NM002B). During the fourteen days of treatment, each PC vessels were supplemented with 10 g/day of each protein once a day. At the end of the treatment, nine days of washout were carried out under the same feeding conditions of the control state. Samples from lumen (PC and DC bioreactors) and mucosa (DC bioreactors) were collected from each colon vessels the day before the beginning of the treatment (C0), after 2, 5, 7, 9, 12 and 14 days of treatment (T02, T05, T07, T09, T12 and T14, respectively), and after 2, 6 and 9 days of wash out (W02, W06 and W09, respectively). Mucin agar-covered microcosms were washed two times by dipping them five times in sterile Ringer’ solution to remove the luminal microbiota, collected in 50 ml tubes and processed following the ProDigest® guideline. The resulting pellet was stored at −20 °C until the DNA extraction. Lumen samples were immediately analysed for the volatile and SCFAs composition. An aliquot of lumen samples was stored at −20 °C until DNA extraction (Supplementary Data 1).

DNA extraction, metataxonomic and metagenomic analyses

Total DNA was extracted from lumen (1 ml) and mucosal samples ( ~ 250 mg of the pellet) using the DNeasy PowerSoil Pro with the QIAcube HT workstation according to the manufacturer’s instructions. Metataxonomic analysis was performed in duplicate. DNA amplification (V3-V4 region of the 16S rRNA gene) and library preparation were performed with the automatic liquid handling Hamilton Microlab® STARTM following the Illumina Sequencing Library Preparation instruction. Amplicon sequencing (2X250 bp) and whole metagenomics shotgun (2X150bp) were performed by the Novogene company (Munich, Germany). For metataxonomic analysis, raw reads were denoised by using QIIME2 software102 and DADA2 plug103. A total of 13.772.008 denoised reads (average 75.670 reads/sample) were used for taxonomic assignment against the Greengenes2 database104. Amplicon sequence variants (ASVs) were averaged between the two replicates and normalized to the lowest number of sequences per sample. The following selected sampling points for both lumen and mucosal from the Triple-M-SHIME, were analysed by shotgun metagenomics: C0, T07, T14, and W09 (Supplementary Data 1). Shotgun data were first filtered for low quality reads, adapters, and for reads shorter than 50bp using adapter removal105. The draft genome of H. sapiens, GRCh38 was used for filtering out human contaminants reads with Bowtie2 v.2.4.4106 in end-to-end sensitive mode. A total of 478 Gbp (Q30 > 99%) of reads were then used for downstream analysis.

Taxonomic assignment and abundance estimation were performed using the Kraken 2 algorithm107, and further refined with Bracken (Bayesian Re-estimation of Abundance with Kraken) following the pipeline presented in ref. 108. Raw reads were normalized using DeSeq2 R package109. Low-abundant hits with a relative abundance lower than 0.001% were filtered out, and all bacteria phyla identified by Kraken2 were cross-referenced with the scientific literature to retain only those with substantial reference support and detect possible contaminants or false positives.

Short reads were then used for functional characterization with Superfocus110 with default paraments. Functional table was then normalized for Copies Per Million (CPM) with Superfocus. Reads were then assembled in contigs with MetaSPAdes v. 3.11.0111. Reads assembled into 863.676 contigs longer than 1000 bp. The total contig length per sample in average was 139.49 Mbp with an average N50 length of 18.136 bp. MAGs (Metagenome-assembled genomes) were obtained from contigs using MetaBat2112, and quality was assessed with CheckM113. Only medium and high-quality MAGs (completeness > 50% and contamination < 10%)114,115 were used for the downstream analysis. Taxonomic assignment in species-level genome bin (SGBs) was performed with Kraken2107. Pangenome calculation and marker gene identification were performed by Tormes116.

Short and medium chain free fatty acids analysis

Short and medium chain free fatty acids were determined by means of capillary gas chromatography coupled with a flame ionization detector (GC/FID), according to the method suggested by ProDigest®117 with slight modifications. Specifically, 1 mL of lumen sample (Supplementary Data 1) was added with 500 μL of a H2SO4:H2O solution (1:1; v/v), a small amount of NaCl (small layer on the back of a glass Pasteur pipette), and 400 μL of NaOH 0.1 M. After vortexing, 4 mL of diethyl ether and 50 μL of internal standard (4-pentenoic acid, 100 mM) were immediately added, and the mixture vortexed again. After centrifugation (1400 × g for 3 min), the top layer was collected and transferred into a GC vial. One microliter was injected in splitless mode (1 min) into a GC/FID Shimadzu GC-2010 equipped with a Stabilwax fused silica capillary column (20 m × 0.18 mm ID × 0.18 μm film thickness; Restek, Bellafonte, PA, USA). The separation was achieved with an oven temperature set up from 40 °C to 248 °C at a rate of 35 °C/min, and held for 8 min. Inlet temperature was 248 °C. Helium was used as carrier gas at a constant linear velocity of 41.0 cm/s. The recognition of the short and medium fatty acids was performed by comparing their retention times with those of the corresponding commercial standards under identical analytical conditions. For quantification, calibration curves for each SCFAs were built in the range 0.1–25.0 mM for the more abundant analytes and a range 0.1–200.0 µM for the less abundant. Results were expressed as millimolar (mM). All analyses were performed in duplicate.

Volatilome profile

Volatile organic compounds (VOCs) were analysed through headspace solid-phase microextraction gas chromatography coupled with mass spectrometry (HS-SPME-GC/MS), following to the procedure described by Ossola et al.118 with some modifications. Briefly, 2 mL of each lumen samples (Supplementary Data 1) were added of 10 µL of 1-octanol (350 µg/mL) as internal standard (IS) in a 20 mL headspace vials sealed with aluminium caps and PTFE silicone septa. The analyses were performed in a GCMS-QP2010 Plus (Shimadzu, Japan), interfaced with a computerized system for data acquisition (Software GC–MS Solution V. 2.5, Shimadzu, Japan). A Combi Pal system was used to incubate each sample at 40 °C for 10 min, where after which a DVB/CAR/PDMS-coated fused silica fibre (10 mm length, df 50/30 µm; Supelco, Bellafonte, PA, USA) was exposed at the same temperature for 40 min. The same fibre was then desorbed in the GC/MS inlet at 260 °C for 5 min (split ratio 1:30). VOCs were separated in a RTX-5 fused silica capillary column (20 m × 0.10 mm ID × 0.10 µm film thickness; Restek, Bellafonte, PA, USA) with the following oven temperature program: from 40 °C (held for 0.70 min) to 220 °C (rate 7 °C/min), and then to 260 °C (rate 20 °C/min), held for 4 min. A constant linear velocity equal to 34.0 cm/s of helium was used (carrier gas). The temperatures of the ion source and the interface were, respectively, 200 °C and 245 °C. Acquisition was performed in scan mode in a m/z range of 50–400 (scan speed 2000 amu/s). Identification of VOCs was achieved with the support of the NIST08s library from the National Institute of Standards and Technology. Blank injections were carried out to exclude environmental contamination. The internal standard method was used to quantify the VOCs, and results were expressed as µg/mL. All analyses were performed in duplicate.

Statistical analyses

To assess differences in total free amino acid (TFAA) concentrations before and after digestion, a one-way Analysis of Variance (ANOVA) was performed using the aov function in R (version 4.4.2). Following ANOVA, Tukey’s Honest Significant Difference (Tukey HSD) post-hoc test was conducted to identify pairwise differences between protein sources. For microbiota analysis, α-diversity and non-metric multidimensional scaling (NMDS) were calculated using the vegan and cmdscale packages in R, respectively. PERMANOVA (999 permutations) and ANOSIM tests were also conducted in R to evaluate differences in community composition. A multi-level indicator species analysis119 was used to identify significant associations between microbial taxa and protein intake across different colonic regions. To explore associations between Amplicon Sequence Variants (ASVs), microbial species, genes, and metabolites, a linear modeling approach was applied using the lmFit function from the limma package in R. A design matrix was created to incorporate protein type, experimental period, gut section, and sampling time as factors. Protein intake was the main variable of interest, with “cricket” set as the reference category. P-values were adjusted for multiple comparisons using the Benjamini–Hochberg procedure to control the False Discovery Rate (FDR). Principal Coordinates Analysis (PCoA) was performed to assess sample clustering based on short-chain fatty acids (SCFAs) and volatile organic compounds (VOCs) profiles. A one-way between-group analysis of Variance (ANOVA) was conducted for acetic, propionic and butyrric acid using the aov function with Tukey’s Honest Significant Difference (Tukey HSD) post-hoc test.

Correlation analysis between log2 normalized data of microbiota and metabolome was conducted using Spearman correlation coefficients on via the corr.test function in R. Only correlations with FDR < 0.01 were visualized. To integrate multiple omics datasets—specifically, taxonomic profiles, metabolomic data, and molecular interaction networks—we employed the R package mixOmics, which is designed for N-integration of heterogeneous data types measured on the same set of samples. Integration was performed using the Data Integration Analysis for Biomarker discovery using Latent Components (DIABLO) framework, also known as multiblock PLS-DA (Partial Least Squares Discriminant Analysis). DIABLO enables simultaneous integration of multiple datasets while modeling their associations with a categorical outcome variable.

Before integration, each dataset was pre-processed through normalization using the scale() function in R, followed by the removal of near-zero variance predictors using the nearZeroVar() function from the caret package. This ensured the stability and interpretability of the multivariate analysis. The R version is 4.4.3, the mixOmics library version is 6.30.0.

Bar plots, boxplots, bubble plots, biplots, corrplot and stacked plots were generated using the ‘ggplot2‘ package in R.

Supplementary information

Supplementary Data 1 (11.9KB, xlsx)
Supplementary Data 2 (104.3KB, xlsx)
Supplementary Data 3 (38.6KB, docx)

Acknowledgements

This publication is part of the project NODES, “NOODLE -alimenti funzionalizzati arricchiti con proteine di grillo e proteine di origine vegetali” which has received funding from the MUR—M4C2 1.5 of PNRR, funded by the European Union—NextGenerationEU, Mission 4 Component 1.5—ECS00000036—CUP D17G22000150001. The authors would like to thank Italian Cricket farm srl. for kindly providing the cricket proteins used in this work.

Author contributions

I.F.: Investigation, data curation, formal analysis, writing—original draft, visualization. G.C.: Formal analysis. C.C.: Formal analysis, methodology, investigation. V.C.: Methodology, Formal analysis. S.B.: Conceptualization, methodology, writing—review and editing. V.P.: Conceptualization, methodology. I.G.: Formal analysis, Methodology. E.P.: Formal analysis, methodology. M.V.: Formal analysis, Methodology. D.T.: Data curation, Software. E.B.: Resources. F.C.: Data curation, software, writing—review and editing. M.B.: Data curation, Software. L.C.: Supervision. I.Fer.: Conceptualization, methodology, resources, supervision, funding acquisition, visualization, writing original draft, writing—review and editing. All authors reviewed the manuscript.

Data availability

The metataxonomic and metagenome sequences are available at the Sequence Read Archive (SRA) of the National Center for Biotechnology Information (NCBI) under the BioProject accession numbers PRJNA1280763and PRJNA1299316, respectively.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

The online version contains supplementary material available at 10.1038/s41538-026-00785-9.

References

  • 1.James, D. et al. Do high-protein diets have the potential to reduce gut barrier function in a sex-dependent manner?. Eur. J. Nutr.63, 2035–2054 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ros-Baró, M. et al. Edible insect consumption for human and planetary health: a Systematic Review. Int. J. Environ. Res. Public Health19, 1–29 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Peterson, C. T. et al. Short-Chain fatty acids modulate healthy gut microbiota composition and functional potential. Curr. Microbiol.79, 1–13 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kang, Y., Oba, P. M., Gaulke, C. A., Sánchez-Sánchez, L. & Swanson, K. S. Dietary inclusion of Yellow Mealworms (T. molitor) and Lesser Mealworms (A. diaperinus) modifies intestinal microbiota populations of diet-induced obesity mice. J. Nutr.153, 3220–3236 (2023). [DOI] [PubMed] [Google Scholar]
  • 5.Wu, S. et al. Effect of dietary protein and processing on gut microbiota—a systematic review. Nutrients14, 1–29 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rinninella, E. et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms7, 14 (2019). [DOI] [PMC free article] [PubMed]
  • 7.Fusco, W. et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients15, 2211 (2023). [DOI] [PMC free article] [PubMed]
  • 8.Krautkramer, K. A., Fan, J. & Bäckhed, F. Gut microbial metabolites as multi-kingdom intermediates. Nat. Rev. Microbiol.19, 77–94 (2021). [DOI] [PubMed] [Google Scholar]
  • 9.Öneş, E., Zavotçu, M., Nisan, N., Baş, M. & Sağlam, D. Effects of kefir consumption on gut microbiota and athletic performance in professional female soccer players: a randomized controlled trial. Nutrients17, 1–20 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bartolome, B. & Moreno-Arribas, M. V. Dynamic Simulation of Food Protein Digestion and Bioactive Peptide Release. In Protein Digestion-Derived Peptides10.1016/B978-0-443-19141-1.00004-2 (Academic Press., 2024).
  • 11.Aguilar-Toalá, J. E., Cruz-Monterrosa, R. G. & Liceaga, A. M. Beyond human nutrition of edible insects: health benefits and safety aspects. Insects13, 1007 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lanng, S. K. et al. Partial substitution of meat with insect (Alphitobius diaperinus) in a carnivore diet changes the gut microbiome and metabolome of healthy rats. Foods10, 1814 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Refael, G. et al. Responses of the human gut microbiota to physiologically digested insect powders or isolated chitin thereof. Futur. Foods6, 100197 (2022). [Google Scholar]
  • 14.de Matos, F. M., Novelli, P. K. & de Castro, R. J. S. Enzymatic hydrolysis of black cricket (Gryllus assimilis) proteins positively affects their antioxidant properties. J. Food Sci.86, 571–578 (2021). [DOI] [PubMed] [Google Scholar]
  • 15.Liceaga, A. M., Aguilar-Toalá, J. E., Vallejo-Cordoba, B., González-Córdova, A. F. & Hernández-Mendoza, A. Insects as an alternative protein source. Annu. Rev. Food Sci. Technol.13, 19–34 (2022). [DOI] [PubMed] [Google Scholar]
  • 16.Magara, H. J. O. et al. Edible crickets (Orthoptera) around the world: distribution, nutritional value, and other benefits — a review. Front. Nutr.7, 1–23 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stull, V. J. et al. Impact of edible cricket consumption on gut microbiota in healthy adults, a double-blind, tandomized crossover trial. Sci. Rep.8, 1–13 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ahern, N., Arendt, E. K. & Sahin, A. W. Protein soft drinks: a retail market analysis and selected product characterization. Beverages9, 1–18 (2023). [Google Scholar]
  • 19.Marotta, R., Pontonio, E., Ferrocino, I. & Filippis, F. De. Alternative proteins and gut health: balancing sustainability and uncertainty. Curr. Opin. Food Sci.66, 101355 (2025). [Google Scholar]
  • 20.Molly, K., Vande Woestyne, M. & Verstraete, W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol.39, 254–258 (1993). [DOI] [PubMed] [Google Scholar]
  • 21.Marzorati, M., Maquet, V. & Possemiers, S. Fate of chitin-glucan in the human gastrointestinal tract as studied in a dynamic gut simulator (SHIME®). J. Funct. Foods30, 313–320 (2017). [Google Scholar]
  • 22.Zhu, W. et al. Simulator of the human intestinal microbial ecosystem (SHIME®): current developments, applications, and future prospects. Pharmaceuticals17, 1639 (2024). [DOI] [PMC free article] [PubMed]
  • 23.Fan, M., Lyu, J. & He, P. Guidelines for data processing and activity questionnaire (IPAQ) – short and long forms. Zhonghua Liu Xing Bing Xue Za Zhi35, 961–964 (2014). [PubMed] [Google Scholar]
  • 24.Bartlett, A. & Kleiner, M. Dietary protein and the intestinal microbiota: an understudied relationship. iScience25, 105313 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Stull, V. J. Impacts of insect consumption on human health. Abstract. J. Insects Food Feed7, 695–713 (2021). [Google Scholar]
  • 26.Boit, T. C., Melse-Boonstra, A., Michaelsen, K. F. & Roos, N. Should we provide edible insects in children’s diets?. Curr. Opin. Clin. Nutr. Metab. Care27, 275–282 (2024). [DOI] [PubMed] [Google Scholar]
  • 27.Hwang, B. B. et al. The edible insect Gryllus bimaculatus protects against gut-derived inflammatory responses and liver damage in mice after acute alcohol exposure. Nutrients11, 857 (2019). [DOI] [PMC free article] [PubMed]
  • 28.Phillips, S. M. Current concepts and unresolved questions in dietary protein requirements and supplements in adults. Front. Nutr.4, 1–10 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rémond, D. et al. Understanding the gastrointestinal tract of the elderly to develop dietary solutions that prevent malnutrition. Oncotarget6, 13858–13898 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Weijzen, M. E. G. et al. Ingestion of free amino acids compared with an equivalent amount of intact protein results in more rapid amino acid absorption and greater postprandial plasma amino acid availability without affecting muscle protein synthesis rates in young adults in a do. J. Nutr.152, 59–67 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gorissen, S. H. M. et al. Protein type, protein dose, and age modulate dietary protein digestion and phenylalanine absorption kinetics and plasma phenylalanine availability in humans. J. Nutr.150, 2041–2050 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Vachher, M., Sen, A., Kapila, R. & Nigam, A. Microbial therapeutic enzymes: a promising area of biopharmaceuticals. Curr. Res. Biotechnol.3, 195–208 (2021). [Google Scholar]
  • 33.Boachie, R. T., Capuano, E., Oliviero, T., Udenigwe, C. C. & Fogliano, V. Undigested glycated lentil proteins modulate the gut microbiota profile but not the metabolites in vitro. J. Funct. Foods107, 105667 (2023). [Google Scholar]
  • 34.Oliphant, K. & Allen-Vercoe, E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome7, 1–15 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gavzy, S. J. et al. Bifidobacterium mechanisms of immune modulation and tolerance. Gut Microbes15, 2291164 (2023). [DOI] [PMC free article] [PubMed]
  • 36.Catassi, C. et al. Diagnosis of non-celiac gluten sensitivity (NCGS): the Salerno experts’ criteria. Nutrients7, 4966–4977 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Skowron, K. et al. The role of psychobiotics in supporting the treatment of disturbances in the functioning of the nervous system—a systematic review. Int. J. Mol. Sci. 23, 7820 (2022). [DOI] [PMC free article] [PubMed]
  • 38.Heeney, D. D., Gareau, M. G. & Marco, M. L. Intestinal Lactobacillus in health and disease, a driver or just along for the ride?. Curr. Opin. Biotechnol.49, 140–147 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Abdugheni, R. et al. Metabolite profiling of human-originated Lachnospiraceae at the strain level. IMeta1, 1–25 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Xu, Y., Zhu, Y., Li, X. & Sun, B. Dynamic balancing of intestinal short-chain fatty acids: the crucial role of bacterial metabolism. Trends Food Sci. Technol.100, 118–130 (2020). [Google Scholar]
  • 41.Folz, J. et al. Human metabolome variation along the upper intestinal tract. Nat. Metab.5, 777–788 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Stefanaki, C., Peppa, M., Mastorakos, G. & Chrousos, G. P. Examining the gut bacteriome, virome, and mycobiome in glucose metabolism disorders: are we on the right track?. Metabolism73, 52–66 (2017). [DOI] [PubMed] [Google Scholar]
  • 43.Van Den Abbeele, P. et al. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J.7, 949–961 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Jie, Z. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun.8, 1–11 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Brahe, L. K. et al. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr. Diabetes5, e159–7 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Grahnemo, L. et al. Identification of three bacterial species associated with increased appendicular lean mass: the HUNT study. Nat. Commun.14, 1–9 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Cui, Y. et al. Roles of intestinal Parabacteroides in human health and diseases. FEMS Microbiol. Lett.369, 1–11 (2022). [DOI] [PubMed] [Google Scholar]
  • 48.Carasi, P., Malamud, M. & Serradell, M. A. Potentiality of food-isolated Lentilactobacillus kefiri strains as probiotics: state-of-art and perspectives. Curr. Microbiol.79, 1–11 (2022). [DOI] [PubMed] [Google Scholar]
  • 49.Sánchez, B. et al. Probiotics, gut microbiota, and their influence on host health and disease. Mol. Nutr. Food Res.61, 1–15 (2017). [DOI] [PubMed] [Google Scholar]
  • 50.Matthies, A., Loh, G., Blaut, M. & Braune, A. Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J. Nutr.142, 40–46 (2012). [DOI] [PubMed] [Google Scholar]
  • 51.Rajilić-Stojanović, M. & de Vos, W. M. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev.38, 996–1047 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Cortez, R. V. et al. Microbiome and its relation to gestational diabetes. Endocrine64, 254–264 (2019). [DOI] [PubMed] [Google Scholar]
  • 53.Matera, M. & Guandalini, S. How the microbiota may affect celiac disease and what we can do. Nutrients16, 1–15 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wang, J. et al. Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus. Gut67, 1614–1625 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Pedersen, H. K. et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature535, 376–381 (2016). [DOI] [PubMed] [Google Scholar]
  • 56.Flemer, B. et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut66, 633–643 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Spatz, M. & Richard, M. L. Overview of the potential role of Malassezia in gut health and disease. Front. Cell. Infect. Microbiol. 10, 201 (2020). [DOI] [PMC free article] [PubMed]
  • 58.Parker, B. J., Wearsch, P. A., Veloo, A. C. M. & Rodriguez-Palacios, A. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front. Immunol.11, 1–15 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Hamilton, M. K., Boudry, G., Lemay, D. G. & Raybould, H. E. Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am. J. Physiol. Gastrointest. Liver Physiol308, G840–G851 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Maskarinec, G. et al. The gut microbiome and type 2 diabetes status in the Multiethnic Cohort. PLoS ONE16, 1–15 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sandhu, K. V. et al. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry. Transl. Res.179, 223–244 (2017). [DOI] [PubMed] [Google Scholar]
  • 62.Dyachkova, M. S. et al. Draft genome sequences of Bifidobacterium angulatum GT102 and Bifidobacterium adolescentis 150: focusing on the genes potentially involved in the gut-brain axis. Genome Announc. 3, e00709-15 (2015). [DOI] [PMC free article] [PubMed]
  • 63.Caffrey, E. B., Sonnenburg, J. L. & Devkota, S. Our extended microbiome: the human-relevant metabolites and biology of fermented foods. Cell Metab36, 684–701 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Camilleri, M., Enteric, C., Translational, N. & Clinic, M. The leaky gut: mechanisms, measurement and clinical implications in humans. Gut68, 1516–1526 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Smith, D. & Jheeta, S. Measuring microbiome effectiveness: a role for ingestible sensors. Gastrointest. Disord.2, 3–11 (2020). [Google Scholar]
  • 66.Wang, C. et al. Roles of intestinal bacteroides in human health and diseases. Crit. Rev. Food Sci. Nutr.0, 1–19 (2020). [DOI] [PubMed] [Google Scholar]
  • 67.Fang, D. et al. Bifidobacterium pseudocatenulatum LI09 and Bifidobacterium catenulatum LI10 attenuate D-galactosamine-induced liver injury by modifying the gut microbiota. Sci. Rep.7, 1–13 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Moreno-Pérez, D. et al. Effect of a protein supplement on the gut microbiota of endurance athletes: a randomized, controlled, double-blind pilot study. Nutrients10, 1–16 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Tarracchini, C. et al. Exploring the vitamin biosynthesis landscape of the human gut microbiota. MSystems9, 1–19 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Yang, Y. et al. Navigating the B vitamins: dietary diversity, microbial synthesis, and human health. Cell Host Microbe32, 12–18 (2024). [DOI] [PubMed] [Google Scholar]
  • 71.Pham, V. T., Dold, S., Rehman, A., Bird, J. K. & Steinert, R. E. Vitamins, the gut microbiome and gastrointestinal health in humans. Nutr. Res.95, 35–53 (2021). [DOI] [PubMed] [Google Scholar]
  • 72.Nie, C., He, T., Zhang, W., Zhang, G. & Ma, X. Branched chain amino acids: beyond nutrition metabolism. Int. J. Mol. Sci. 19, 954 (2018). [DOI] [PMC free article] [PubMed]
  • 73.Vangsoe, M. T., Thogersen, R., Bertram, H. C., Heckmann, L. H. L. & Hansen, M. Ingestion of insect protein isolate enhances blood amino acid concentrations similar to soy protein in a human trial. Nutrients10, 1357 (2018). [DOI] [PMC free article] [PubMed]
  • 74.Moran-Ramos, S. et al. A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents. Mol. Med. 27, 108 (2021). [DOI] [PMC free article] [PubMed]
  • 75.Collins, F. W. J. et al. Bacteriocin gene-trait matching across the complete lactobacillus pan-genome. Sci. Rep.7, 1–14 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Fonknechten, N. et al. Clostridium sticklandii, a specialist in amino acid degradation: revisiting its metabolism through its genome sequence. BMC Genomics11, 555 (2010). [DOI] [PMC free article] [PubMed]
  • 77.Garcia-Mantrana, I., Selma-Royo, M., Alcantara, C. & Collado, M. C. Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population. Front. Microbiol.9, 1–11 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R. & Rastall, R. A. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat. Rev. Gastroenterol. Hepatol.16, 605–616 (2019). [DOI] [PubMed] [Google Scholar]
  • 79.Companys, J. et al. Gut microbiota profile and its association with clinical variables and dietary intake in overweight/obese and lean subjects: a cross-sectional study. Nutrients13, 2032 (2021). [DOI] [PMC free article] [PubMed]
  • 80.Ríos-Covián, D. et al. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol.7, 1–9 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Cani, P. D. Human gut microbiome: Hopes, threats and promises. Gut67, 1716–1725 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Al-Lahham, S. H., Peppelenbosch, M. P., Roelofsen, H., Vonk, R. J. & Venema, K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim. Biophys. Acta Mol. Cell Biol. Lipids1801, 1175–1183 (2010). [DOI] [PubMed] [Google Scholar]
  • 83.Tilg, H. & Moschen, A. R. Microbiota and diabetes: an evolving relationship. Gut 1–9 10.1136/gutjnl-2014-306928 (2014). [DOI] [PubMed]
  • 84.Roopashree, P. G., Shetty, S. S. & Suchetha Kumari, N. Effect of medium chain fatty acid in human health and disease. J. Funct. Foods87, 104724 (2021). [Google Scholar]
  • 85.Schönfeld, P. & Wojtczak, L. Short- and medium-chain fatty acids in energy metabolism: the cellular perspective. J. Lipid Res.57, 943–954 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Matsue, M. et al. Measuring the antimicrobial activity of lauric acid against various bacteria in human gut microbiota using a new method. Cell Transplant28, 1528–1541 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Raimondi, S. et al. Multivariate analysis in microbiome description: correlation of human gut protein degraders, metabolites, and predicted metabolic functions. Front. Microbiol. 12, 723479 (2021). [DOI] [PMC free article] [PubMed]
  • 88.Zhao, J., Zhao, F., Yuan, J., Liu, H. & Wang, Y. Gut microbiota metabolites, redox status, and the related regulatory effects of probiotics. Heliyon9, e21431 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Canfora, E. E., Feitelson, M. A. & Arzumanyan, A. Editorial: Microbiome metabolites in health and disease. Front. Microbiol. 14, 1270001 (2023). [DOI] [PMC free article] [PubMed]
  • 90.Song, J. et al. Dietary inulin supplementation modulates short-chain fatty acid levels and cecum microbiota composition and function in chickens infected with Salmonella. Front. Microbiol.11, 1–15 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Young, W. et al. Feeding bugs to bugs: edible insects modify the human gut microbiome in an in vitro fermentation model. Front. Microbiol.11, 1–12 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Brodkorb, A. et al. INFOGEST static in vitro simulation of gastrointestinal food digestion. Nat. Protoc.14, 991–1014 (2019). [DOI] [PubMed] [Google Scholar]
  • 93.Weiss, W., Vogelmeier, C. & Görg, A. Electrophoretic characterization of wheat grain allergens from different cultivars involved in bakers’ asthma. Electrophoresis14, 805–816 (1993). [DOI] [PubMed] [Google Scholar]
  • 94.Verni, M. Determination of the content of free amino acids and their profiling. In Basic Methods and Protocols on Sourdough 71–79 (Springer Nature, 2024).
  • 95.Martínez-González, M. A. et al. A 14-item mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial. PLoS ONE7, e43134 (2012). [DOI] [PMC free article] [PubMed]
  • 96.Craig, C. L. et al. International physical activity questionnaire: 12-Country reliability and validity. Med. Sci. Sports Exerc.35, 1381–1395 (2003). [DOI] [PubMed] [Google Scholar]
  • 97.Schröder, H. et al. Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin. Nutr.20, 429–437 (2001). [DOI] [PubMed] [Google Scholar]
  • 98.Ferrocino, I. et al. Fecal microbiota in healthy subjects following omnivore, vegetarian and vegan diets: culturable populations and rRNA DGGE profiling. PLoS ONE10, 1–16 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Da Ros, A. et al. Feeding with sustainably sourdough bread has the potential to promote the healthy microbiota metabolism at the colon level. Microbiol. Spectr.9, e00494-21 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Castelnuovo, G., Perez-Diaz-Del-Campo, N., Dubois, S., Franciosa, I. & Bugianesi, E. Potential application of the simulator of the human intestinal microbial ecosystem in metabolic dysfunction-associated steatotic liver disease. Minerva Biotechnol. Biomol. Res.36, 217–225 (2024). [Google Scholar]
  • 101.Van Herreweghen, F. et al. In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent. Benef. Microbes8, 81–96 (2017). [DOI] [PubMed] [Google Scholar]
  • 102.Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol.37, 852–857 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods13, 581–583 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.McDonald, D. et al. Greengenes2 unifies microbial data in a single reference tree. Nat. Biotechnol.42, 715–718 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Schubert, M., Lindgreen, S. & Orlando, L. AdapterRemoval v2: rapid adapter trimming, identification, and read merging. BMC Res. Notes9, 1–7 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods9, 357–359 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol20, 1–13 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Lu, J. et al. Metagenome analysis using the Kraken software suite. Nat. Protoc.17, 2815–2839 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15, 1–21 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Silva, G. G. Z., Green, K. T., Dutilh, B. E. & Edwards, R. A. SUPER-FOCUS: a tool for agile functional analysis of shotgun metagenomic data. Bioinformatics32, 354–361 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Nurk, S. et al. Assembling single-cell genomes and mini-metagenomes from chimeric MDA products. J. Comput. Biol.20, 714–737 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Kang, D. D. et al. MetaBAT 2: an adaptive binning algorithm for robust and efficient genome reconstruction from metagenome assemblies. PeerJ2019, 1–13 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P. & Tyson, G. W. CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res25, 1043–1055 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Bowers, R. M. et al. Minimum information about a single amplified genome (MISAG) and a metagenome-assembled genome (MIMAG) of bacteria and archaea. Nat. Biotechnol.35, 725–731 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Buzzanca, D. et al. Delving into Roccaverano PDO cheese: a comprehensive examination of microbial diversity and flavour profiles compared to non-PDO cheeses. Int. J. Food Microbiol.429, 111014 (2025). [DOI] [PubMed] [Google Scholar]
  • 116.Quijada, N. M., Rodríguez-Lázaro, D., Eiros, J. M. & Hernández, M. TORMES: an automated pipeline for whole bacterial genome analysis. Bioinformatics35, 4207–4212 (2019). [DOI] [PubMed] [Google Scholar]
  • 117.De Boever, P., Deplancke, B. & Verstraete, W. Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder. J. Nutr.130, 2599–2606 (2000). [DOI] [PubMed] [Google Scholar]
  • 118.Ossola, M. et al. Does microbiome matter in chronic intestinal failure due to Type 1 short bowel syndrome in adults? Nutrients16, 2282 (2024). [DOI] [PMC free article] [PubMed]
  • 119.De Cáceres, M., Legendre, P. & Moretti, M. Improving indicator species analysis by combining groups of sites. Oikos119, 1674–1684 (2010). [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data 1 (11.9KB, xlsx)
Supplementary Data 2 (104.3KB, xlsx)
Supplementary Data 3 (38.6KB, docx)

Data Availability Statement

The metataxonomic and metagenome sequences are available at the Sequence Read Archive (SRA) of the National Center for Biotechnology Information (NCBI) under the BioProject accession numbers PRJNA1280763and PRJNA1299316, respectively.


Articles from NPJ Science of Food are provided here courtesy of Nature Publishing Group

RESOURCES